Pfizer Suspends Chronic Pain Drug Tanezumab Clinical Trial
Reportedly, investigation of the compound continues in some areas of high unmet medical need, including cancer pain. Considering of reports of adverse events in osteoarthritis patients taking Tanezumab,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.